Moderna, Inc. MRNA
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$229.69$245.37
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 181.00% | 5.21% | -38.31% | 26.25% | -1,638.46% |
| Total Depreciation and Amortization | 30.77% | 10.53% | 51.28% | 11.67% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.52% | -21.92% | -4.72% | -12.16% | 21.43% |
| Change in Net Operating Assets | -133.62% | 126.60% | 362.09% | -10.25% | 52.69% |
| Cash from Operations | -84.06% | 42.76% | 39.25% | 12.73% | 45.91% |
| Capital Expenditure | -42.42% | -1,133.33% | 47.01% | 92.53% | 78.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -327.56% | -35.45% | -101.65% | 47.06% | -15.94% |
| Cash from Investing | -345.00% | -41.67% | -110.41% | 91.09% | -2.91% |
| Total Debt Issued | -- | -- | -- | 15,100.00% | -- |
| Total Debt Repaid | -233.33% | -133.33% | -- | -20.00% | -- |
| Issuance of Common Stock | 6,400.00% | 64.29% | 533.33% | 45.45% | -75.00% |
| Repurchase of Common Stock | -- | -- | -100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 274,600.00% | 55.56% | 325.00% | 19,466.67% | -109.09% |
| Foreign Exchange rate Adjustments | 0.00% | -300.00% | -- | 100.00% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -259.18% | 46.38% | -127.06% | 418.79% | 82.35% |